Abstract Number: 827 • 2012 ACR/ARHP Annual Meeting
Sustained Development of Cardiovascular Disease in Rheumatoid Arthritis Despite Cardioprotective Treatment: The 10-Year Prospective Carre-Study
Background/Purpose: Rheumatoid arthritis (RA) is a chronic inflammatory joint disease which is associated with an increased cardiovascular (CV) risk. It is still unknown to what…Abstract Number: 828 • 2012 ACR/ARHP Annual Meeting
Association between Anti-Tumor Necrosis Factor Therapy and the Risk of Ischemic Stroke in Subjects with Rheumatoid Arthritis. Results From the British Society for Rheumatology Biologics Registers-Rheumatoid Arthritis (BSRBR-RA)
Background/Purpose: Subjects with rheumatoid arthritis (RA) are at increased risk of cardiovascular (CV) morbidity and mortality, with some studies suggesting an increased risk of stroke…Abstract Number: 829 • 2012 ACR/ARHP Annual Meeting
Subcutaneous Nodules Are Significantly Associated with Cardiovascular Events in Patients with Rheumatoid Arthritis: Results From a Very Large US Registry
Background/Purpose: Cardiovascular Disease (CVD) is now recognized to be a major comorbidity of patients with rheumatoid arthritis. Predictors of CVD have been shown to include…Abstract Number: 830 • 2012 ACR/ARHP Annual Meeting
Five-Year Favourable Outcome of Patients with Early Rheumatoid Arthritis in the 2000s: Data From the Espoir Cohort
Background/Purpose: To report the five-year outcome of a large national multicentre, longitudinal and prospective cohort of patients with very early arthritis and rheumatoid arthritis (RA)…Abstract Number: 831 • 2012 ACR/ARHP Annual Meeting
A Randomized, Double-Blind, Placebo-Controlled, Multiple-Dose Study to Evaluate the Safety, Tolerability, and Efficacy of Brodalumab (AMG 827) in Subjects with Rheumatoid Arthritis and an Inadequate Response to Methotrexate
Background/Purpose: A potential role for IL-17 in rheumatoid arthritis (RA) has been supported by data from clinical studies of inhibitors of the IL-17A ligand. To…Abstract Number: 832 • 2012 ACR/ARHP Annual Meeting
Peroxisome Proliferator-Activated Receptor Gamma Agonist Treatment for Rheumatoid Arthritis: A Proof-of-Concept Randomized Controlled Trial
Background/Purpose: Rheumatoid arthritis (RA), a chronic inflammatory disease, is associated with insulin resistance. Experimental evidence indicates that the relationship between insulin resistance and inflammation is…Abstract Number: 793 • 2012 ACR/ARHP Annual Meeting
Associations of Foot Forces and Pressures to Regional Foot Pain: The Framingham Foot Study
Background/Purpose: Foot pain is a risk factor for disability; however, not all foot pain is the same. Foot pain etiology can vary by region (e.g.,…Abstract Number: 794 • 2012 ACR/ARHP Annual Meeting
How Many Steps/Day Are Associated with a Community Level Gait Speed Among Older Adults with or At High Risk of Knee OA?
Background/Purpose: While recommended levels of physical activity associated with reducing the risk of poor health outcomes are well known, it is unclear what minimal level…Abstract Number: 795 • 2012 ACR/ARHP Annual Meeting
Racial Differences in Pain Coping Efficacy in Patients with Hip and Knee Osteoarthritis
Background/Purpose: Studies have shown that African Americans with osteoarthritis (OA) have greater pain than Caucasians. However, little is known about whether there are racial differences…Abstract Number: 796 • 2012 ACR/ARHP Annual Meeting
African American Adults Less Willing to Undergo Joint Replacement Surgery: The Multicenter Osteoarthritis Study
Background/Purpose: “Willingness” to undergo joint replacement surgery (JRS) is predictive of subsequent JRS among community-dwelling older adults and could, at least in part, explain the…Abstract Number: 797 • 2012 ACR/ARHP Annual Meeting
Clinical and Biomechanical Characteristics of Total Hip Arthroplasty Responders and Nonresponders
Background/Purpose: In a recent study, 14% of total hip arthroplasty (THA) patients were classified as nonresponders, using osteoarthritis (OA) treatment response criteria1. Identifying characteristics of…Abstract Number: 798 • 2012 ACR/ARHP Annual Meeting
A Rich Description of Clinical Exam Features in Patients with Knee Osteoarthritis and Their Correlation with Functional Outcomes
Background/Purpose: Assessments of symptomatic knee osteoarthritis (KOA) rely on physical measures for clinical decision-making. However, there is limited literature on the association between examination procedures…Abstract Number: 799 • 2012 ACR/ARHP Annual Meeting
Does Unpredictable Intermittent Knee Pain Limit Functional Ability and Walking Frequency in Knee OA?
Background/Purpose: People with knee osteoarthritis (OA) reported that unpredictable pain restricts their ability to engage in physical activities in a qualitative study. Since walking is…Abstract Number: 800 • 2012 ACR/ARHP Annual Meeting
BMI, Occupational Activity, and Leisure-Time Physical Activity: an Exploration of Risk Factors and Modifiers for Knee Osteoarthritis
Background/Purpose: Risk of knee osteoarthritis (OA) is increased by obesity, and also by physical activities which mechanically stress the joint. The few studies which have…Abstract Number: 801 • 2012 ACR/ARHP Annual Meeting
Symptom Improvement in Fibromyalgia Patients Is Related to Reduced Network Connectivity As Measured by EEG Coherence
Background/Purpose: To assess changes in brain functional network connectivity (FC) in fibromyalgia (FM) patients treated with Reduced Impedance Noninvasive Cortical Electrostimulation (RINCE). Previous studies using…